The renin angiotensin system in the development of cardiovascular disease: role of aliskiren in risk reduction

References

• AldermanMHMadhavanSOoiWL1991Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertensionN Engl J Med32410981041759997
   PubMed Web of Science ®Google Scholar
• AldermanMHOoiWLCohenH1997Plasma renin activity: a risk factor for myocardial infarction in hypertensive patientsAm J Hypertens10189008242
   PubMed Web of Science ®Google Scholar
• AndersenKWeinbergerMHEganB2007Aliskiren-based therapy lowers blood pressure more effectively than ramipril-based therapy in patients with hypertension: a 6-month, randomized, double-blind trialJ Am Coll Cardiol49Suppl AA371
   Google Scholar
• AziziMMenardJBisseryA2004Pharmacologic demonstration of the synergistic effects of a combination of the renin inhibitor aliskiren and the AT1 receptor antagonist valsartan on the angiotensin II-renin feedback interruptionJ Am Soc Nephrol1531263315579516
   PubMed Web of Science ®Google Scholar
• BaderMGantenD2008Update on tissue renin-angiotensin systemsJ Mol Med866152118414822
   PubMed Web of Science ®Google Scholar
• BrunnerHRLaraghJHBaerL1972Essential hypertension: renin and aldosterone, heart attack and strokeN Engl J Med28644194257928
   PubMed Web of Science ®Google Scholar
• CampbellDJWoodwardMChalmersJP2005Prediction of myocardial infarction by N-terminal-pro-B-type natriuretic peptide, C-reactive protein, and renin in subjects with cerebrovascular diseaseCirculation112110615983245
   PubMed Web of Science ®Google Scholar
• ClausmeyerSSturzebecherRPetersJ1999An alternative transcript of the rat renin gene can result in a truncated prorenin that is transported into adrenal mitochondriaCirc Res843374410024308
   PubMed Web of Science ®Google Scholar
• DahlofBAndersonDRAroraV2007Aliskiren, a direct renin inhibitor, provides antihypertensive efficacy and excellent tolerability independent of age or gender in patients with hypertensionJ Clin Hypertens9Suppl AA157
   Google Scholar
• DanserAHBatenburgWWvan EschJH2008Prorenin anno 2008J Mol Med86655818322669
   PubMed Web of Science ®Google Scholar
• DanserAHDerkxFHSchalekampMA1998Determinants of interindividual variation of renin and prorenin concentrations: evidence for a sexual dimorphism of (pro)renin levels in humansJ Hypertens16853629663926
   PubMed Web of Science ®Google Scholar
• DanserAHvan den DorpelMADeinumJ1989Renin, prorenin, and immunoreactive renin in vitreous fluid from eyes with and without diabetic retinopathyJ Clin Endocrinol Metab6816072642484
   PubMed Web of Science ®Google Scholar
• DerkxFHAlberdaATde JongFH1987Source of plasma prorenin in early and late pregnancy: observations in a patient with primary ovarian failureJ Clin Endocrinol Metab65349542439529
   PubMed Web of Science ®Google Scholar
• DerkxFHSchalekampMA1988Human prorenin: pathophysiology and clinical implicationsClin Exp Hypertens A101213253066528
   PubMedGoogle Scholar
• DieterleWCorynenSMannJ2004Effect of the oral renin inhibitor aliskiren on the pharmacokinetics and pharmacodynamics of a single dose of warfarin in healthy subjectsBr J Clin Pharmacol58433615373937
   PubMed Web of Science ®Google Scholar
• DieterleWCorynenSVaidyanathanS2005Pharmacokinetic interactions of the oral renin inhibitor aliskiren with lovastatin, atenolol, celecoxib and cimetidineInt J Clin Pharmacol Ther435273516300168
   PubMed Web of Science ®Google Scholar
• DonoghueMHsiehFBaronasE2000A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1–9Circ Res87E1910969042
   PubMed Web of Science ®Google Scholar
• DoyleAEJerumsGJohnstonCI1973Plasma renin levels and vascular complications in hypertensionBr Med J2586020674700008
   PubMedGoogle Scholar
• FukamizuASugimuraKTakimotoE1993Chimeric renin-angiotensin system demonstrates sustained increase in blood pressure of transgenic mice carrying both human renin and human angiotensinogen genesJ Biol Chem26811617218505294
   PubMed Web of Science ®Google Scholar
• GantenDWagnerJZehK1992Species specificity of renin kinetics in transgenic rats harboring the human renin and angiotensinogen genesProc Natl Acad Sci U S A897806101502199
   PubMed Web of Science ®Google Scholar
• GradmanAHSchmiederRELinsRL2005aAliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patientsCirculation1111012815723979
   PubMed Web of Science ®Google Scholar
• GradmanAHSchmiederRELinsRL2005bAliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patientsCirculation1111012815723979
   PubMed Web of Science ®Google Scholar
• HuangYWongamornthamSKastingJ2006Renin increases mesangial cell transforming growth factor-beta1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanismsKidney Int691051316374430
   PubMed Web of Science ®Google Scholar
• IchiharaASuzukiFNakagawaT2006Prorenin receptor blockade inhibits development of glomerulosclerosis in diabetic angiotensin II type 1a receptor-deficient miceJ Am Soc Nephrol1719506116738017
   PubMed Web of Science ®Google Scholar
• ItskovitzJRubattuSLevronJ1992Highest concentrations of prorenin and human chorionic gonadotropin in gestational sacs during early human pregnancyJ Clin Endocrinol Metab75906101517384
   PubMed Web of Science ®Google Scholar
• ItskovitzJSealeyJEGlorioso1987Plasma prorenin response to human chorionic gonadotropin in ovarian-hyperstimulated women: correlation with the number of ovarian follicles and steroid hormone concentrationsProc Natl Acad Sci U S A84728593118364
   PubMed Web of Science ®Google Scholar
• JacobyDSRaderDJ2003Renin-angiotensin system and atherothrombotic disease: from genes to treatmentArch Intern Med16311556412767951
   PubMed Web of Science ®Google Scholar
• JamesMNSieleckiAR1985Stereochemical analysis of peptide bond hydrolysis catalyzed by the aspartic proteinase penicillopepsinBiochemistry243701133899173
   PubMed Web of Science ®Google Scholar
• JordanJEngeliSBoyeSW2007Direct renin inhibition with aliskiren in obese patients with arterial hypertensionHypertension4910475517353513
   PubMed Web of Science ®Google Scholar
• KushiroTItakuraHAboY2006Aliskiren, a novel oral renin inhibitor, provides dose-dependent efficacy and placebo-like tolerability in Japanese patients with hypertensionHypertens Res29997100517378372
   PubMed Web of Science ®Google Scholar
• LuetscherJAKraemerFBWilsonDM1985Increased plasma inactive renin in diabetes mellitus. A marker of microvascular complicationsN Engl J Med312141273887168
   PubMed Web of Science ®Google Scholar
• McInnesGT2007Renin inhibition: the holy grail of renin-angiotensin system blockade?J Hum Hypertens21766917541389
   PubMed Web of Science ®Google Scholar
• McMurrayJJVPittBLatiniRfor the Aliskiren Observation of Heart Failure Treatment, I2008Effects of the oral direct renin inhibitor aliskiren in patients with symptomatic heart failureCirc Heart Fail11724
   PubMed Web of Science ®Google Scholar
• MeadeTWCooperJAPeartWS1993Plasma renin activity and ischemic heart diseaseN Engl J Med32961698341336
   PubMed Web of Science ®Google Scholar
• MenardJGuyeneTTPeyrardS2006Conformational changes in prorenin during renin inhibition in vitro and in vivoJ Hypertens245293416467656
   PubMed Web of Science ®Google Scholar
• MitchellJOhBHerronJ2006Once-daily aliskiren provides effective, smooth 24-h blood pressure control in patients with hypertensionJ Clin Hypertens8Suppl AA93
   Google Scholar
• NabiAHKageshimaAUddinMN2006Binding properties of rat prorenin and renin to the recombinant rat renin/prorenin receptor prepared by a baculovirus expression systemInt J Mol Med18483816865234
   PubMed Web of Science ®Google Scholar
• NguyenG2006Renin/prorenin receptorsKidney Int691503616672920
   PubMed Web of Science ®Google Scholar
• NguyenGDanserAH2006The (pro)renin receptor: therapeutic consequencesExpert Opin Investig Drugs1511315
   PubMed Web of Science ®Google Scholar
• NguyenGDelarueFBurckleC2002Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to reninJ Clin Invest10914172712045255
   PubMed Web of Science ®Google Scholar
• NussbergerJWuerznerGJensenC2002Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalaprilHypertension39E1811799102
   PubMed Web of Science ®Google Scholar
• OhBHMitchellJHerronJR2007Aliskiren, an oral renin inhibitor, provides dose-dependent efficacy and sustained 24-hour blood pressure control in patients with hypertensionJ Am Coll Cardiol4911576317367658
   PubMed Web of Science ®Google Scholar
• OliverJA2006Receptor-mediated actions of renin and proreninKidney Int6913516374416
   PubMed Web of Science ®Google Scholar
• OparilSYarowsSAPatelS2007Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension: a randomised, double-blind trialLancet3709583221917658393
   PubMed Web of Science ®Google Scholar
• ParvingHHPerssonFLewisJB2008Aliskiren combined with losartan in type 2 diabetes and nephropathyN Engl J Med35824334618525041
   PubMed Web of Science ®Google Scholar
• PilzBShagdarsurenEWellnerM2005Aliskiren, a human renin inhibitor, ameliorates cardiac and renal damage in double-transgenic ratsHypertension465697616103264
   PubMed Web of Science ®Google Scholar
• PoolJLSchmiederREAziziM2007Aliskiren, an orally effective renin inhibitor, provides antihypertensive efficacy alone and in combination with valsartanAm J Hypertens20112017198906
   PubMed Web of Science ®Google Scholar
• PriceDAPorterLEGordonM1999The paradox of the low-renin state in diabetic nephropathyJ Am Soc Nephrol1023829110541298
   PubMed Web of Science ®Google Scholar
• RahuelJRasettiVMaibaumJ2000Structure-based drug design: the discovery of novel nonpeptide orally active inhibitors of human reninChem Biol749350410903938
   PubMed Web of Science ®Google Scholar
• ReudelhuberTLRamlaDChiuL1994Proteolytic processing of human prorenin in renal and non-renal tissuesKidney Int46152247699995
   PubMed Web of Science ®Google Scholar
• Schmidt-OttKMKagiyamaS2000The multiple actions of angiotensin II in atherosclerosisRegul Pept93657711033054
   PubMed Web of Science ®Google Scholar
• SealeyJEGoldsteinMPitarresiT1988Prorenin secretion from human testis: no evidence for secretion of active renin or angiotensinogenJ Clin Endocrinol Metab6697483283163
   PubMed Web of Science ®Google Scholar
• SieleckiARHayakawaKFujinagaM1989Structure of recombinant human renin, a target for cardiovascular-active drugs, at 2.5 A resolutionScience24348961346512493678
   PubMed Web of Science ®Google Scholar
• SkeggsLTJrKahnJRLentzK1957The preparation, purification, and amino acid sequence of a polypeptide renin substrateJ Exp Med1064395313463253
   PubMed Web of Science ®Google Scholar
• SolomonSD2008Effect of the direct renin inhibitor aliskiren, either alone or in combination with losartan, compared to losartan, on left ventricular mass in patients with hypertension and left ventricular hypertrophy: The Aliskiren Left Ventricular Assessment of Hypertrophy (ALLAY) TrialSCAI-ACC i2Summit/American College of Cardiology Annual Scientific SessionChicago, IL
   Google Scholar
• StantonAJensenCNussbergerJ2003Blood pressure lowering in essential hypertension with an oral renin inhibitor, aliskirenHypertension4211374314597641
   PubMed Web of Science ®Google Scholar
• StrasserRHPuigJGFarsangC2007A comparison of the tolerability of the direct renin inhibitor aliskiren and lisinopril in patients with severe hypertensionJ Hum Hypertens217807
   Google Scholar
• TheOI2008Telmisartan, ramipril, or both in patients at high risk for vascular eventsN Engl J Med35815475918378520
   PubMed Web of Science ®Google Scholar
• TurnerAJ2003Exploring the structure and function of zinc metallopeptidases: old enzymes and new discoveriesBiochem Soc Trans31723712773192
   PubMed Web of Science ®Google Scholar
• UresinYTaylorAKiloC2006Aliskiren, a novel renin inhibitor, has greater BP lowering than ramipril and additional BP lowering when combined with ramipril in patients with diabetes and hypertensionJ Hypertens24Suppl 482
   Google Scholar
• van KesterenCADanserAHDerkxFH1997Mannose 6-phosphate receptor-mediated internalization and activation of prorenin by cardiac cellsHypertension301389969403558
   PubMed Web of Science ®Google Scholar
• VillamilAChrysantSGCalhounD2007Renin inhibition with aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazideJ Hypertens251726
   Google Scholar
• WaldmeierFGlaenzelUWirzB2007Absorption, distribution, metabolism, and elimination of the direct renin inhibitor aliskiren in healthy volunteersDrug Metab Dispos3541828
   Web of Science ®Google Scholar
• WeirMBushCZhangJ2006Antihypertensive efficacy and safety of the oral renin inhibitor aliskiren in patients with hypertension: a pooled analysisEur Heart J27Suppl299
   Google Scholar
• Wilkinson-BerkaJL2004Diabetes and retinal vascular disorders: role of the renin-angiotensin systemExpert Rev Mol Med611815387897
   PubMedGoogle Scholar
• WoodJMMaibaumJRahuelJ2003Structure-based design of aliskiren, a novel orally effective renin inhibitorBiochem Biophys Res Commun30869870512927775
   PubMed Web of Science ®Google Scholar
• WoodJMSchnellCRCuminF2005Aliskiren, a novel, orally effective renin inhibitor, lowers blood pressure in marmosets and spontaneously hypertensive ratsJ Hypertens234172615662231
   PubMed Web of Science ®Google Scholar
• WoodJMStantonJLHofbauerKG1987Inhibitors of renin as potential therapeutic agentsJ Enzyme Inhib1169853334243
   PubMedGoogle Scholar